Wednesday
SESSION 26: NEW DEVELOPMENTS IN DRUG COATED BALLOONS (DCBs) AND DRUG ELUTING STENTS (DESs): UPDATES ON RANDOMIZED CONTROLLED TRIALS (RCTs) AND BTK LESION TREATMENTS WITH DCBs AND DESs
Location: Grand Ballroom East, 3rd Floor
Moderators:Joseph L. Mills, MD / John R. Laird, MD  
SESSION 26 SCHEDULE
NEW INFORMATION ON DCBs AND DESs FOR FEMPOP LESIONS: UPDATES ON RCTs
10:18 AM - 10:23 AM Cost Effectiveness Analysis Of Drug Eluting Technologies For Femoropopliteal Lesions Show That They Are Worth The Increased Device Costs
  Presenter(s):Stefan Mueller-Huelsbeck, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
10:24 AM - 10:29 AM Stellarex (Philips) DCBs With Low Dose Paclitaxel Is Safe And Has Higher Patency Rates Than POBA With Fempop Lesions At 5 Years In The ILLUMENATE US And European RCTs: There Was No Paclitaxel Mortality Signal
  Presenter(s):Sean P. Lyden, MD / Marianne Brodmann, MD / Sahil A. Parikh, MD / William A. Gray, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
10:30 AM - 10:35 AM Pooled Data From The In.Pact RCT And Real World DCB Trials For SFA-Pop Lesions Show Safety And Efficacy For 5 Years Compared To POBA: Will The Advantage Of DCBs Diminish With Time
  Presenter(s):Peter A. Schneider, MD / John R. Laird, MD / Thomas Zeller, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
10:36 AM - 10:41 AM New Findings From The DRASTICO Study Comparing DESs To DCBs For Fempop Lesions: 5-Year Results With TASC A/B Lesions Versus TASC C/D Lesions
  Presenter(s):Francesco Liistro, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
10:42 AM - 10:47 AM Value Of In.Pact DCBs For Long Complex SFA-Pop Lesions Including ISR And CTOs: Technical Tips And Contraindications: From The Global Registry: What Is The Best Endo Treatment For These Lesions
  Presenter(s):Gunnar Tepe, MD / Marianne Brodmann, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
10:48 AM - 10:53 AM Update On The Randomized Head To Head Comparison Of In.Pact (Medtronic) And Ranger (Boston Scientific) DCBs For Complex SFA Lesions: 2-Year Results Of The COMPARE RCT: Similar Results With Different Paclitaxel Dosages
  Presenter(s):Dierk Scheinert, MD / Sabine Steiner, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
10:54 AM - 10:59 AM

Power Point Presentation with Synched Audio
Update On The Global RANGER II RCT Comparing Ranger DCBs With POBA: How Does It Help Us Determine The Best Treatment For Long Complex ATK Lesions
  Presenter(s):Marianne Brodmann, MD  
Location: Grand Ballroom East, 3rd Floor
11:00 AM - 11:05 AM New Information On The Safety And Effectiveness Of The Cook Zilver PTX DES Based On Global Trials Including A RCT: When Is It The Best Treatment
  Presenter(s):Michael D. Dake, MD  
Location: Grand Ballroom East, 3rd Floor
11:06 AM - 11:11 AM 2-Year Results Of The IMPERIAL RCT Head To Head Comparison Of The Zilver PTX DES (Cook) With The Eluvia DES (Boston Scientific): Both Are Safe And Effective: Is There A Difference
  Presenter(s):Stefan Mueller-Huelsbeck, MD / William A. Gray, MD / Thomas Zeller, MD  
Location: Grand Ballroom East, 3rd Floor
11:12 AM - 11:18 AM Panel Discussion
NEW INFORMATION ON BTK DCBs AND DESs
11:18 AM - 11:23 AM Advances In BTK Drug Delivery Technology And DCBs: What Have We Learned From The In.Pact Deep BTK DCB Trial And New Challenges With Treating CLTI Patients
  Presenter(s):Thomas Zeller, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
11:24 AM - 11:29 AM The Sirolimus DCB BTK Era Begins Current Experience With The Selution DEB And Design Of The SELUTION SLR .014 BTK IDE Trial: Early Results From Singapore And Europe
  Presenter(s):Patrick J. Geraghty, MD  
Location: Grand Ballroom East, 3rd Floor
11:30 AM - 11:35 AM Orbital Vessel Preparation To Maximize DCB Efficacy In Calcified BTK Lesions: OPTIMIZE BTK RCT 1-Year Results
  Presenter(s):Thomas Zeller, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
11:36 AM - 11:41 AM

Power Point Presentation with Synched Audio
3-Year Results From The AcoArt II BTK DCB RCT Show Safety With No Increased Mortality And Improved Patency Versus POBA
  Presenter(s):Wei Guo, MD / Francesco Liistro, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
11:42 AM - 11:47 AM Why Some BTK DCB Trials Have Not Shown Uniformly Better Results: Technical And Balloon Factors Matter
  Presenter(s):Francesco Liistro, MD  
Location: Grand Ballroom East, 3rd Floor
11:48 AM - 11:53 AM Update On The SAVAL Trial With A Self-Expanding DES (From Boston Scientific) For BTK Occlusive Lesions
  Presenter(s):Miguel F. Montero, MD / Jihad A. Mustapha, MD  
Location: Grand Ballroom East, 3rd Floor
11:54 AM - 12:00 PM Panel Discussion
12:00 PM - 1:00 PM Lunch Break Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 26
previous next